Governments are moving toward approving the first vaccines to contain Covid-19, but public concerns about dosage safety are threatening to undermine those efforts.
A survey by the University of Hamburg found that about 40% of respondents in seven European countries were hesitant or unwilling to prepare for the Covid-19 vaccine in November. An October poll by market researcher Ipsos found that about a third of Japanese and about half of French respondents said they would not inoculate for coronavirus.
Heidi Larsen, an anthropologist at the London School of Hygiene and Tropical Medicine and director of the Vaccine Confidence Project, a group that believes in the vaccine world, said U.S. And in some places like Italy, vaccine suspects are advancing this fear. Wide. “There’s a lot of worry,” he said.
The biggest factor behind hesitation is the speed at which things are moving.
With cases of Covid-19 growing, governments in the West are under intense pressure to bring life back to normal. The UK, which ended its second lockdown in England last week, was joined by Pfizer Inc. on Wednesday. And approved for emergency use of the Bioentech SE vaccine. Inoculations are expected to begin this week.
.
